Key Pediatric Clinical Practice Guidelines in 2017

Seasonal Allergic Rhinitis

Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma, and Immunology; and American College of Allergy, Asthma, and Immunology

For patients aged 12 years and older, nasal symptoms of SAR should be treated at least initially with an INCS (intranasal corticosteroid) alone rather than the INCS–oral antihistamine combination.

For initial treatment of moderate to severe SAR in patients 15 years and older, the clinician should recommend an INCS over an LTRA (leukotriene receptor antagonist).

The clinician may recommend combination therapy with an INCS and an INAH over either monotherapy, albeit with increased cost and some increased risk for side effects (intranasal antihistamine).

References

• Harrison P. New Guidelines for Allergic Rhinitis Change Treatment. Medscape News. WebMD Inc. November 9, 2017. https://www.medscape.com/viewarticle/888269

• Dykewicz MS, Wallace DV, Baroody F, et al. Treatment of Seasonal Allergic Rhinitis: An Evidence-Based Focused 2017 Guideline Update. Ann Allergy Asthma Immunol. 2017 Nov 2. http://www.annallergy.org/article/S1081-1206%2817%2930656-7/addons

Medscape © 2018 WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Key Pediatric Clinical Practice Guidelines in 2017 - Medscape - Jan 10, 2018.